Kelee® Meditation: A Distinctive and Effective Therapeutic Intervention for Stress, Anxiety, and Depression

NCT01527955 | Completed

• 1 other identifier: IRB Project#081197
• Study Type: interventional
• Target: 47
• Locations: 1 country
• Sites: 2

Brief Summary

The purpose of this study is to determine how effective Kelee meditation is in improving stress, anxiety, and depression.

Conditions

Stress; Anxiety; Depression

Keywords

Kelee; Meditation; Stress; Anxiety; Depression; Brain; Mind

Outcome Measures

Primary Outcomes (1)

• Change in Total Score of Depression, Anxiety, and Stress Scales-42 (DASS-42)

  The DASS is a set of 3 self-report scales designed to measure the negative emotional states of depression, anxiety and stress and to further the process of defining, understanding, and measuring the ubiquitous and clinically significant emotional states usually described as depression, anxiety and stress. Each of the 3 DASS scales contains 14 items. Subjects are asked to use 4-point severity/frequency scales to rate the extent to which they have experienced each state over the past week. Scores for Depression, Anxiety and Stress are calculated by summing the scores for the relevant items.

  From Week 0 (baseline) to Week 12

Secondary Outcomes (8)

• Change in Depression Subscale Score of DASS-42

  From Week 0 (baseline) to Week 12

• Change in Anxiety Subscale Score of DASS-42

  From Week 0 (baseline) to Week 12

• Change in Stress Subscale Score of DASS-42

  From Week 0 (baseline) to Week 12

• Change in Total Score of Beck Depression Inventory-II (BDI-II)

  From Week 0 (baseline) to Week 12

• Change in Total Score of Beck Anxiety Inventory (BAI)

  From Week 0 (baseline) to Week 12

Interventions

Kelee Meditation OTHER

The participants were instructed on how to perform Kelee Meditation (KM) at the initial session. This was followed by a comprehensive review of the Kelee principles and reference points over the subsequent 12 weeks. At the beginning of each weekly session, a group meditation was performed, which was followed by individual introspection and contemplation. Participants recorded their observations and experiences in a KM journal. Each participant had the opportunity to share his own journal entry and to ask questions about his own observations and experiences since starting KM. Participants were encouraged to perform the KM practice 10 minutes twice daily throughout the 12 weeks of the study.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Documented HIV-1 infection
• Ages 18 to 65
• Experiencing some level of stress, anxiety, or depression
• No current use of other meditation practices or holistic modalities

You may not qualify if:

• Non-English readers or speakers
• Hearing-impaired
• Low literacy below 5th grade reading and comprehension level

Sponsors & Collaborators

• University of California, San Diego: lead

Study Sites (2)

Being Alive San Diego

San Diego, California, 92103, United States

Location

University of California, San Diego Medical Center

San Diego, California, 92103, United States

Location

Related Links

• Kelee Foundation website for more information about Kelee Meditation

MeSH Terms

Conditions

Anxiety Disorders; Depression

Condition Hierarchy (Ancestors)

Mental Disorders; Behavioral Symptoms; Behavior

Study Officials

• Daniel Lee, MD

  University of California, San Diego

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Clinical Professor of Medicine

Study Record Dates

• First Submitted: February 2, 2012
• First Posted: February 7, 2012
• Study Start: September 1, 2008
• Primary Completion: September 1, 2010
• Study Completion: June 1, 2011
• Last Updated: February 7, 2012

Record last verified: 2012-02

Locations

US (2)